30 reports

  • CAUSES OF GASTRIC CANCER
  • Gastric cancer drugs market in EMEA
  • Gastric Cancer
  • Eli Lilly & Co.
  • F. Hoffmann-La Roche Ltd.
  • Otsuka Pharmaceutical Co., Ltd.
  • Sanofi S.A.
  • Gastric Cancer, Stage Grouping
  • Pipeline for Gastric Cancer, Global, 2016
  • Gastric Cancer
  • World
  • Market Size
  • AstraZeneca PLC
  • Roche Group

Key Features of the Report: - Gastric Cancer Patient Flow - Gastric Cancer Prevalence - Gastric Cancer Diagnosed Patients - Gastric Cancer Treated Patients

  • Gastric Cancer
  • Europe
  • France
  • World
  • Forecast

Gastric cancer

4546 5000 3864
  • FORECAST: GASTRIC CANCER
  • Pipeline: Gastric Cancer
  • Gastric Cancer
  • Asia
  • Japan
  • Eli Lilly & Co.
  • Merck & Co., Inc.
  • Risk Factors and Comorbidities for Gastric Cancer
  • MM, Sources of Gastric Cancer Incidence Data
  • Gastric Cancer
  • China
  • Japan
  • World
  • Forecast

Gastric Cancer Drugs - R& D, Trends and Market Forecasts 2016-2026 ##.

  • Cancer
  • Gastric Cancer
  • Therapy
  • World
  • Market Size

Key Features of the Report: - Gastric Cancer Patient Flow - Gastric Cancer Prevalence - Gastric Cancer Diagnosed Patients - Gastric Cancer Treated Patients

  • Gastric Cancer
  • Europe
  • France
  • Germany
  • Forecast

This report analyzes in detail the gastric cancer markets.

  • Cancer
  • Gastric Cancer
  • Pathology
  • World
  • Market Size

Gastric Cancer -Epidemiology Forecast to 2027 ##.

  • Gastric Cancer
  • France
  • Germany
  • Italy
  • Spain

Gastric Cancer Forecast and Market Analysis to 2024 FORECAST: GASTRIC CANCER (Published on ## December 2017) EXECUTIVE SUMMARY RECENT FORECAST UPDATES MARKET DYNAMICS FORECAST AND FUTURE TRENDS MARKET DEFINITION AND METHODOLOGY PRIMARY RESEARCH METHODOLOGY BIBLIOG

  • Cancer
  • Gastric Cancer
  • Pathology
  • Europe
  • Japan

Gastric Cancer : ##MM Market Analysis ##. ##. ##MM Market Size of Gastric Cancer ##. ##. ##MM Percentage Share of drugs marketed for Gastric Cancer ##. ##. ##MM Market Sales of Gastric Cancer by Products ##.

  • Gastric Cancer
  • France
  • Germany
  • Italy
  • Spain
  • NIMOTUZUMAB'S DEVELOPMENT IN GASTRIC CANCER
  • SYMPTOMS OF GASTRIC CANCER
  • Gastric Cancer
  • Eli Lilly & Co.
  • Merck & Co., Inc.
  • Roche Group
  • Taiho Pharmaceutical Co., Ltd.

STAT## has been suggested as a marker of poor prognosis in a variety of cancer indications, including colorectal cancer, non-small cell lung cancer, and gastric cancer.

  • Colorectal Cancer
  • Gastric Cancer
  • Lung Cancer
  • Europe
  • Japan
  • SYMPTOMS OF GASTRIC CANCER
  • DEVELOPMENT OF ABRAXANE IN GASTRIC CANCER
  • Gastric Cancer
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Roche Group
  • Taiho Pharmaceutical Co., Ltd.
  • STAGE DEFINITIONS FOR GASTRIC CANCER
  • NIMOTUZUMAB'S DEVELOPMENT IN GASTRIC CANCER
  • Gastric Cancer
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Roche Group
  • Taiho Pharmaceutical Co., Ltd.
  • STAGE DEFINITIONS FOR GASTRIC CANCER
  • SYMPTOMS OF GASTRIC CANCER
  • Gastric Cancer
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Roche Group
  • Taiho Pharmaceutical Co., Ltd.
  • STAGE DEFINITIONS FOR GASTRIC CANCER
  • NIMOTUZUMAB'S DEVELOPMENT IN GASTRIC CANCER
  • Gastric Cancer
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Roche Group
  • Taiho Pharmaceutical Co., Ltd.
  • LATEST CLINICAL TRIALS NEWS ON GASTRIC CANCER
  • GASTRIC CANCER THERAPEUTICS, E7 COUNTRIES, CLINICAL TRIALS BY TRIAL STATUS, 2017*
  • Chemotherapy
  • Clinical Trial
  • Gastric Cancer
  • Therapy
  • World
  • DIFFERENT TYPES OF GASTRIC CANCER
  • 5.2 GLOBAL GASTRIC CANCER MARKET
  • Gastric Cancer
  • United States
  • World
  • Market Size
  • Merck & Co., Inc.
  • Gastric Cancer, Pancreatic Cancer
  • Gastric Cancer, Metastatic Cancer, Metastatic Lung Cancer
  • Clinical Trial
  • Gastric Cancer
  • Therapy
  • World
  • F. Hoffmann-La Roche Ltd.
  • Gastric Cancer - Overview
  • Gastric Cancer - Discontinued Products
  • Gastric Cancer
  • Monoclonal Antibody
  • North America
  • United States
  • Product Initiative
  • Gastric Cancer - Drug Profiles
  • Gastric Cancer - Dormant Projects
  • Gastric Cancer
  • Monoclonal Antibody
  • North America
  • United States
  • Product Initiative
  • Gastric Cancer, Tumor, Node and Metastasis
  • Gastric Cancer, Molecular Targets in Pipeline
  • Cancer
  • Gastric Cancer
  • Pathology
  • Therapy
  • GASTRIC CANCER
  • GASTRIC CANCER
  • Cancer
  • Esophageal Cancer
  • Gastric Cancer
  • Pharmaceutical
  • Merck & Co., Inc.
  • Clinical Trial profile. 233 Trial Title
  • Clinical Trial profile. 66 Trial Title
  • Clinical Trial
  • Gastric Cancer
  • Lung Cancer
  • World
  • Product Initiative
  • Apr 21, 2016: Imugene submits regulatory package for HER-Vaxx Phase 1b/2 study in gastric cancer
  • Sep 20, 2016: Imugene successfully completes preclinical animal studies
  • Gastric Cancer
  • Therapy
  • Australia
  • M&A
  • Imugene Limited
  • DIAGNOSTIC TEST - GASTRIC CANCER
  • DIAGNOSTIC TEST - GASTRIC CANCER - PRODUCT DESCRIPTION
  • Colorectal Cancer
  • Diabetes
  • Gastric Cancer
  • Pharmacy
  • Miraculins Inc.
  • PROGNOSTIC ASSAY - GASTRIC CANCER
  • DIAGNOSTIC ASSAY - GASTRIC CANCER
  • Gastric Cancer
  • Genomics
  • Spain
  • Company
  • Oryzon Genomics S.A.
  • Tyrosine Protein Kinase CSK (C Src Kinase or Protein Tyrosine Kinase CYL or CSK or EC 2.7.10.2) - Product Development Milestones
  • Products under Development by Companies, H2 2017
  • Gastric Cancer
  • Targeted Therapy
  • Therapy
  • Product Initiative
  • Pfizer Inc.
  • Jul 05, 2016: Five Prime Therapeutics Receives FDA Orphan Drug Designation for FPA144 for the Treatment of Gastric Cancer
  • 04/20/2017: Five Prime to Present Clinical Data on FPA144 at 2017 ASCO Annual Meeting
  • Gastric Cancer
  • Pharmaceutical
  • United States
  • Company
  • Five Prime Therapeutics, Inc.